7月30日,心通医疗-B早盘持续上涨11.11%,现报1.50港元。此前,微创医疗与心通医疗联合公告,拟将心通医疗与微创CRM业务重组,以整合资源、提升竞争力。微创CRM业务主要涵盖起搏器、除颤器等心律管理产品。分析指出,整合后有望实现销售渠道共享,形成覆盖结构性心脏病与心律管理的平台型公司,增强全球市场影响力。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.